AIMC Topic: Hemagglutinin Glycoproteins, Influenza Virus

Clear Filters Showing 11 to 12 of 12 articles

Broadly active intranasal influenza vaccine with a nanocomplex particulate adjuvant targeting mast cells and toll-like receptor 9.

Journal of controlled release : official journal of the Controlled Release Society Aug 10, 2025
Flumist is the only FDA-approved intranasal influenza vaccine. Although it has recently been approved for at-home use, it has significant limitations. These include reduced effectiveness in generating a protective immune response in patients with ext...
Humans Female Animals Mice Nanoparticles Mice, Inbred BALB C Mast Cells Adjuvants, Immunologic Influenza Vaccines Orthomyxoviridae Infections Administration, Intranasal Oligodeoxyribonucleotides Hemagglutinin Glycoproteins, Influenza Virus Toll-Like Receptor 9
View on PubMed DOI

Examining the Influenza A Virus Sialic Acid Binding Preference Predictions of a Sequence-Based Convolutional Neural Network.

Influenza and other respiratory viruses Dec 1, 2024
BACKGROUND: Though receptor binding specificity is well established as a contributor to host tropism and spillover potential of influenza A viruses, determining receptor binding preference of a specific virus still requires expensive and time-consumi...
Humans Neural Networks, Computer Machine Learning Influenza A virus Protein Binding Amino Acid Sequence Influenza, Human Hemagglutinin Glycoproteins, Influenza Virus Receptors, Virus N-Acetylneuraminic Acid
View on PubMed DOI
Popular Topics
Recent Journals